Skip to main content
MS-DRG 673 · MDC 11 · Surgical

MS-DRG 673: Other Kidney and Urinary Tract Procedures with MCC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 673

FY2027 relative weight
4.2525
Higher than 87% of all MS-DRGs
Change vs FY2026
+1.2%
FY2026 weight 4.2016
Geometric mean LOS
10.0 days
Arithmetic mean 13.0 days
MDC
11
Diseases and Disorders of the Kidney and Urinary Tract
Severity level
with MCC (major complication or comorbidity)
National unadjusted operating payment
$29,121.12
Weight × $6,848.00 FY2027 standardized amount; capital adds $2,296.14
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 673 is a surgical group in MDC 11 (Diseases and Disorders of the Kidney and Urinary Tract), at the highest of three severity levels in its CC/MCC family. CMS assigns it a FY2027 relative weight of 4.2525 with a geometric mean length of stay of 10.0 days and an arithmetic mean of 13.0. Its weight moved up 1.2% from FY2026 (4.2016). That weight is higher than 87% of all MS-DRGs. Its weight sits 89.0% above DRG 674 (with CC, 2.2504) and 167.7% above DRG 675 (without CC/MCC, 1.5887). The v44 Definitions Manual assigns it through 1,768 operating room procedures codes and 25 principal diagnosis codes and 2 secondary diagnosis codes and 30 non-operating room procedures codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 673 the FY2027 relative weight is 4.2525 against 4.2016 in FY2026, a rise of 1.21%.

FY2026 versus FY2027 payment factors for MS-DRG 673
MetricFY2026FY2027Change
Relative weight4.20164.2525+0.0509
Geometric mean LOS (days)10.210.0-0.2
Arithmetic mean LOS (days)13.113.0-0.1
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 673 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 1.5887 to 4.2525, a 2.68× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 673
DRGTitleFY2027 weightGMLOSNational operating payment
673Other Kidney and Urinary Tract Procedures with MCC4.252510.0$29,121.12
674Other Kidney and Urinary Tract Procedures with CC2.25045.3$15,410.74
675Other Kidney and Urinary Tract Procedures without CC/MCC1.58872.9$10,879.42

At the national rate, documenting the family's top severity level (DRG 673, $29,121.12) instead of its base level (DRG 675, $10,879.42) changes the operating payment by $18,241.70, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 673

Multiplying the FY2027 relative weight (4.2525) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $18,241.70.

FY2027 national unadjusted IPPS payment for MS-DRG 673
ComponentNational rateDRG 673
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$29,121.12
Capital (federal rate)$539.95$2,296.14
Operating plus capital$31,417.26
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $28,210.19 to $28,893.40 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 673.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 25 ICD-10-CM codes in the logic for DRG 673; 7 of them also map to a CMS-HCC V28 payment category, across 2 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 673
V28 HCCCategoryShared codesExamples
HCC 326Chronic Kidney Disease, Stage 54I12.0, I13.11, N18.5
HCC 37Diabetes with Chronic Complications3E10.22, E11.22, E13.22

New for FY2027: codes that group to DRG 673

IPPS Tables 6A and 6B assign 6 new ICD-10-PCS codes to DRG 673 from October 1, 2026. Encoders and edit tables that still run the v43 code set reject these codes or group them elsewhere, so check them first when a FY2027 discharge in this DRG fails an edit. The FY2027 ICD-10 code-change report lists every addition and deletion with its CC level and MS-DRGs.

New FY2027 ICD-10-PCS codes that group to DRG 673
ICD-10-PCSDescriptionO.R.Effective
X0HQ05CInsertion of Leadless Neurostimulator Generator into Vagus Nerve, Open Approach, New Technology Group 12Yes2026-10-01
X2723CBDilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11Yes2026-04-01
X2VJ3HCRestriction of Thoracic Aorta, Ascending and Arch using Branched Intraluminal Device, Integrated System with Innominate Branch, Percutaneous Approach, New Technology Group 12Yes2026-10-01
X2VW3JCRestriction of Thoracic Aorta, Descending using Branched Intraluminal Device, Integrated System Extension, Percutaneous Approach, New Technology Group 12Yes2026-10-01
X2VX0KCRestriction of Thoracic Aorta, Arch using Branched Intraluminal Device, with Conical Collar, Open Approach, New Technology Group 12Yes2026-10-01
XFJD4CCInspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12Yes2026-10-01

Grouper logic (v44 Definitions Manual)

The manual's split table for Other Kidney and Urinary Tract Procedures gives one row per combination of criteria and the MS-DRG it assigns. DRG 673 is the row where MCC is Yes.

Split table for Other Kidney and Urinary Tract Procedures
MCCCCDRG
Yesnot checked673
NoYes674
NoNo675

Operating Room Procedures: 1768 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown.

Operating Room Procedures codes in the logic for DRG 673 (sample)
ICD-10-PCS codeDescription
00HE0MZInsertion of Neurostimulator Lead into Cranial Nerve, Open Approach
00HE3MZInsertion of Neurostimulator Lead into Cranial Nerve, Percutaneous Approach
00HE4MZInsertion of Neurostimulator Lead into Cranial Nerve, Percutaneous Endoscopic Approach
00HU0MZInsertion of Neurostimulator Lead into Spinal Canal, Open Approach
00HU3MZInsertion of Neurostimulator Lead into Spinal Canal, Percutaneous Approach
00HU4MZInsertion of Neurostimulator Lead into Spinal Canal, Percutaneous Endoscopic Approach
00HV0MZInsertion of Neurostimulator Lead into Spinal Cord, Open Approach
00HV3MZInsertion of Neurostimulator Lead into Spinal Cord, Percutaneous Approach
00HV4MZInsertion of Neurostimulator Lead into Spinal Cord, Percutaneous Endoscopic Approach
00PU0MZRemoval of Neurostimulator Lead from Spinal Canal, Open Approach
00PU3MZRemoval of Neurostimulator Lead from Spinal Canal, Percutaneous Approach
00PU4MZRemoval of Neurostimulator Lead from Spinal Canal, Percutaneous Endoscopic Approach

Principal Diagnosis: 25 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown. The manual joins this list to the one before it with "or".

Principal Diagnosis codes in the logic for DRG 673 (sample)
ICD-10-CM codeDescription
E88.3Tumor lysis syndrome
I12.0Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
N17.0Acute kidney failure with tubular necrosis
N17.1Acute kidney failure with acute cortical necrosis
N17.2Acute kidney failure with medullary necrosis
N17.8Other acute kidney failure
N17.9Acute kidney failure, unspecified
N18.5Chronic kidney disease, stage 5
N18.6End stage renal disease
N19Unspecified kidney failure
R34Anuria and oliguria

Secondary Diagnosis: 2 ICD-10-CM codes in this DRG's assignment logic. The manual joins this list to the one before it with "with".

Secondary Diagnosis codes in the logic for DRG 673 (sample)
ICD-10-CM codeDescription
N18.5Chronic kidney disease, stage 5
N18.6End stage renal disease

Non-Operating Room Procedures: 30 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown. The manual joins this list to the one before it with "and".

Non-Operating Room Procedures codes in the logic for DRG 673 (sample)
ICD-10-PCS codeDescription
0JH60XZInsertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach
0JH63WZInsertion of Totally Implantable Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach
0JH63XZInsertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach
0JH80XZInsertion of Tunneled Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach
0JH83WZInsertion of Totally Implantable Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach
0JH83XZInsertion of Tunneled Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHD0XZInsertion of Tunneled Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHD3WZInsertion of Totally Implantable Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHD3XZInsertion of Tunneled Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHF0XZInsertion of Tunneled Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHF3WZInsertion of Totally Implantable Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHF3XZInsertion of Tunneled Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach

Code editor, HAC and CC/MCC exclusion notes for DRG 673

Table 6K part 3 excludes 2 secondary diagnoses from acting as a CC or MCC in MS-DRGs 673-675 (Other Kidney and Urinary Tract Procedures), because they are part of the group's own logic: N18.5, N18.6 and others. On a stay in this family they do not move it to the with-CC or with-MCC member; the CC/MCC list shows every family with such exclusions.

1 procedure code in this DRG's logic is on the procedure list of HAC 14 (Iatrogenic Pneumothorax with Venous Catheterization), for example 0JH63XZ. When the condition that category tracks is coded as a secondary diagnosis with a present-on-admission indicator of N or U after one of these procedures, the grouper does not count it as a CC or MCC. The FY2027 HAC list gives the diagnoses and procedures of each category.

The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 673; these are the ones that are also on a Medicare Code Editor list and can draw that edit.

Medicare Code Editor v44 lists that include codes in the logic of DRG 673
MCE editListCodesExamples
Edit 11diagnosis that makes a pancreas transplant alone covered1E10.22

Documentation and denial exposure

As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 11 with a lower weight. The inpatient claim reports that procedure in ICD-10-PCS, which NCCI does not edit; the surgeon's professional claim for the same operation carries CPT and HCPCS codes, and the NCCI pair checker for those professional codes shows whether two of them bundle. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 673

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 673

What is MS-DRG 673?

MS-DRG 673 is "Other Kidney and Urinary Tract Procedures with MCC", a surgical Medicare Severity Diagnosis-Related Group in MDC 11 (Diseases and Disorders of the Kidney and Urinary Tract). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 673?

The FY2027 relative weight is 4.2525 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 4.2016, a change of +1.2%.

What is the Medicare base payment for MS-DRG 673?

$29,121.12 for operating costs plus $2,296.14 for capital, $31,417.26 together, at the FY2027 national rates: weight 4.2525 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 674 (with CC) comes to $15,410.74 operating on the same basis. DRG 675 (without CC/MCC) comes to $10,879.42 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 673?

CMS reports a geometric mean length of stay of 10.0 days and an arithmetic mean of 13.0 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 673?

DRG 674 (with CC, weight 2.2504, GMLOS 5.3 days); DRG 675 (without CC/MCC, weight 1.5887, GMLOS 2.9 days). Together with DRG 673 the family spans 1.5887 to 4.2525, a 2.68x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 673?

DRG 673 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.

Which codes group to DRG 673?

The v44 Definitions Manual lists 1,768 operating room procedures codes and 25 principal diagnosis codes and 2 secondary diagnosis codes and 30 non-operating room procedures codes for this group. Examples from the operating room procedures list, 00HE0MZ (Insertion of Neurostimulator Lead into Cranial Nerve, Open Approach); 00HE3MZ (Insertion of Neurostimulator Lead into Cranial Nerve, Percutaneous Approach); and from the principal diagnosis list, E88.3 (Tumor lysis syndrome); I12.0 (Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease).

Is DRG 673 a post-acute transfer DRG?

No. DRG 673 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.